• Skip to main content
  • Skip to navigation
  • Accessibility
  • Contact Us
Government of Western Australia Crest
Government of Western Australia
Government of Western Australia Crest

Additional Menu

  • Accessibility
  • Contact us
Go to WA Government search
  • About us
    • Our Vision and Values
    • Strategic Plan
    • Our Team
      • Health Service Board
    • Customer Service
      • Provide Your Feedback
      • Customer Service Charter
      • Freedom of Information
      • Public Interest Disclosure
      • Quality Management
    • Work With Us
      • Vacancies
      • Pathways to Working With Us
      • Diversity and Inclusion
    • Research & Partnerships
    • Education
      • HLT37215 Certificate III in Pathology Collection
    • Annual Reports
    • Contact us
    • Locations
  • Our Services
    • Clinical Services
      • Anatomical Pathology
      • Biochemistry
      • Diagnostic Genomics
      • Forensic Services
      • Haematology & Blood Transfusion
      • Immunology
      • Microbiology
      • Point-of-Care Testing
    • Commercial Services
      • Food and Water Testing
      • Health & Workplace Testing
      • Media Manufacturing
      • Pharmaceutical Testing
      • Request a Quote
      • Resources
    • Perinatal Pathology
      • Information for Families
      • Information for Health Professionals
      • Information for Funeral Directors
    • PCH Mortuary
      • Information for Families
      • Information for Health Professionals
    • Clinical Trials and Research
    • State Mortuary Bereavement Centre
  • For Health Professionals
    • Service Updates
    • Test Directory and Resources
    • Requesting Pathology
    • Respiratory Pathogen Dashboard
    • Results
  • Electronic Results Delivery
  • For Patients
    • Find a Collection Centre
    • Infant and Child Tests
    • Preparing for Your Test
    • Measles
    • Mpox (monkeypox)
    • Pay a Bill
      • Hospital Inpatients
      • Medicare Rebates
    • Your Results
    • Your Safety
  • Latest News
  1. Home
  2. Latest News

Latest News

Latest News

  • IPAA Wastewater Award 19 December 2025 Congratulations to our PathWest QEII Microbiology team, one of a group of agencies, to be recognised for its work with the WA Wastewater Surveillance Program at the 2025 Institute of Public Administration Australia WA (IPPA WA) Achievement Awards. The Awards demonstrate through research excellence, innovation and collaboration, how PathWest plays a significant role in improving the health, wellbeing and safety of the Western Australian community. The PathWest team, the Communicable Disease Control Directorate and Environmental Health, Water Corporation, Boorloo Public Health Unit (North Metropolitan Health Service) and WA Country Health Service won the Award for Best Practice in Collaboration Across Government Organisations (Category 1- project < $1million) and the Silver Award for Best Practice in Innovation (Category 1- project < $1million). Western Australia was the first jurisd...
  • PathWest (Forensic Biology) and ChemCentre win the 2025 WA Government Innovator of the Year Award 18 November 2025 We congratulate our PathWest (Forensic Biology) team, who jointly with ChemCentre, have been named the 2025 Western Australian Government Innovator of the Year. The Award, announced recently by Science and Medical Research Minister Stephen Dawson at the 19th annual Western Australian Innovators of the Year Awards, recognises world-first research by ChemCentre and the PathWest (Forensic Biology) R...
  • Overall Cake Entries - high resolution
    PathWest BakeWest - Entries for Overall Winner 04 August 2025 Please note: Voting closed on Thursday 7 August 2025. Overall Winner Cake Entries Genes and germs by Avril Strutt (People, Capability and Culture) Named ‘Genes and Germs’, this colourful retro-inspired cake was created as a school holiday activity with Avril and her children – a celebration of both creativity and science. The name playfully reflects both the cake and the creators. - The ‘P’ ca...
  • Celebrating 20 years of PathWest - July 2025
    Celebrating 20 years of PathWest 01 August 2025 Last month, we marked two decades of PathWest with special morning teas and site displays at our Queen Elizabeth II (QEII) and Fiona Stanley Hospital (FSH) sites. The morning tea at QEII was attended by the Department of Health Director General, Dr Shirley Bowen, our Chief Executive Dr Narelle Hadlow, Board Chair Angie Paskevicius, and staff from across PathWest. As part of the celebrations, we ...
  • Discontinuation of Genetic Testing for Chronic Idiopathic Pancreatitis
    Discontinuation of Genetic Testing for Chronic Idiopathic Pancreatitis 30 May 2025 Following a recent review, PathWest will discontinue genetic testing for chronic idiopathic pancreatitis (CIP) from 03 June 2025. This decision follows a clinical and operational review which identified: CIP testing is not supported by Medicare. Current CIP testing has limited clinical utility in comparison to the international benchmark: Low diagnostic yield of less than 10% compared...

Read more news

  • Biochemistry FSH Consultant Chemical Pathologist becomes the Editor-in-Chief of RCPA’s Journal 15 March 2024 Congratulations to Dr John Burnett on his appointment as the new Editor-in-Chief of the Royal College of Pathologists of Australasia (RCPA) Pathology Journal, announced at the RCPA Pathology Update 2024 Editorial Board Meeting. Read RCPA’s post on LinkedIn for more information.
  • Rare Disease Day 2024 15 March 2024 Rare Disease Day is celebrated globally on 29 February 2024 raising awareness to improve the access to diagnosis and treatment for those living with a rare disease, their families and carers. At PathWest, we have organised a number of events to acknowledge the significance of this day, highlighting the outstanding work of our teams in paving the way for scientific advancement, treatment and a brighter future for those affected by rare diseases. Joined by our guest speaker, Andrew Bannister, Ambassador of Rare Voices Australia, our Chief Executive Dr Narelle Hadlow, Board Chair Ms Angie Paskevicius, Diagnostic Genomics Head of Department Dr Dimitar Azmanov, Board Member Mr Tony Vis, Acting Chief Pathologist Dr David Smith, Biochemistry QEII Head of Department Dr Simon Carrivick and other PathWest staff, we not only recognise the rarity of these diseases but also the strength, courage, a...
  • Immunosuppressant service changes to 7 days per week starting on 7 January 2024 06 February 2024 PathWest has commenced the seven-day-per-week immunosuppressant service. Registrars will be exempt from the obligation to contact the on-call pathologists at PathWest to obtain authorisation to send samples on weekends.To facilitate an efficient workflow and assure prompt delivery of service, please note the following sample processing times and kindly distribute this information to other staff members. To obtain same day results (by 4 pm) for Tacrolimus, Sirolimus, Everolimus, and Cyclosporin test requests, samples must be received in testing laboratory (CBPT, QEII MC, Level 1, PP Block, Hospital Avenue, Nedlands, WA 6009): Monday - Saturday by 2pm, and Sundays/public holidays by 1pm. Please note: Specimens received after 2pm Monday – Saturday and after 1pm Sundays and public holidays will be assayed and reported the following day Critically urgent Tacrolimus ...
  • Pioneering cancer advancements - PathWest's collaborative initiatives on World Cancer Day 05 February 2024 World Cancer Day, observed annually on 4 February, serves as a reminder of the global collaboration essential in the ongoing battle against cancer. At the forefront of this collaborative effort is the PathWest Community Health and Hospital Program, spearheading a $19 million initiative in Western Australia dedicated to Comprehensive Genomic Profiling (CGP) for all cancer patients. This ground-breaking endeavour leverages state-of-the-art massively parallel sequencing technology, marking a significant stride in the pursuit of advanced cancer diagnosis and treatment. CGP is an integral aspect of the program which serves as a transformative tool that identifies biomarkers, guiding tailored treatment strategies and instilling hope for those facing exhaustive conventional treatment options. The program's commitment extends to ensuring equitable cancer care for all Western Australian patients...
  • Sampling time recommendations for mast cell tryptase in association with suspected event causing mast cell activation 22 December 2023 This service update is regarding PathWest sampling time recommendations for mast cell tryptase in association with a suspected event causing mass cell activation (e.g. anaphylaxis). The changes are in line with sampling times recommended in UK and Australian guidelines published by the Australian and New Zealand Anaesthetic Allergy Group (ANZAAG), National Institute for Health and Care Excellence (NICE) and British Society of Allergy & Clinical Immunology (BSACI). Sample collections for mast cell tryptase are now recommended to be taken: Close to 1-2 hours after the event (no later than 4 hours), and At least 24 hours after the event to obtain a baseline level. These recommendations are now updated on the PathWest Test Directory. Download an information flyer. Please contact the Immunology support team for more information on (08) 6383 4303.
Previous12345678910...21Next
Last Updated: 20/05/2025
  • Facebook
  • LinkedIn

Footer menu

  • wa.gov.au
  • Copyright
  • Disclaimer
  • Privacy
  • Sitemap
  • Contact Us

Brought to you by the Department of Health, Western Australia

© Government of Western Australia 2018 to